Research progress of neoadjuvant therapy in adenocarcinoma of the esophagogastric junction / 国际肿瘤学杂志

Surgery alone for the adenocarcinoma of the esophagogastric junction (AEG) often gives unsatisfactory results, with a poor prognosis.At present, there is no unified therapeutic regimen specifically for AEG.Neoadjuvant therapy includes neoadjuvant radiotherapy, chemotherapy and chemoradiotherapy, but the applications and effects of them for AEG are still controversial.